Market Overview

Morgan Stanley Downgrades FactSet On Valuation, Organic Growth Prospects

Share:
Morgan Stanley Downgrades FactSet On Valuation, Organic Growth Prospects

Shares of FactSet Research Systems Inc. (NYSE: FDS) seem fully valued, following the year-to-date rally and given expectations of organic growth decelerating in 2020, according to Morgan Stanley.

The Analyst

Morgan Stanley’s Toni Kaplan downgraded FactSet Research Systems from Equal-Weight to Underweight, while reducing the price target from $264 to $263.

The Thesis

FactSet Research Systems’ stock has appreciated around 47% year to date, outperforming Morgan Stanley’s Analytics coverage average and the S&P 500, Kaplan said in the downgrade note.

Most of the share price rally has been driven by multiple expansion, with investors seeking high quality stocks, the analyst mentioned. He expressed concern, however, regarding the company’s earnings growth prospects.

Kaplan mentioned that FactSet’s EPS growth in 2020 may fall to the lowest that the company has generated in the last four years. This is expected due to moderating annual subscription value (ASV), along with lower margin expansion.

While ASV growth at Research, which accounted for 46% of 2018 ASV, could turn negative, pricing pressure is expected to intensify with growing competition, the analyst said.

Following the share price rally, FactSet’s stock now trades at a premium to many Analytics stocks that have better growth prospects.

Price Action

Shares of FactSet Research Systems dropped 3.5% to $283.81 at time of publication.

Related Links

Benzinga's Top Upgrades, Downgrades For July 16, 2019

30 Stocks Moving In Tuesday's Pre-Market Session

Latest Ratings for FDS

DateFirmActionFromTo
Jul 2019DowngradesEqual-WeightUnderweight
Jun 2019MaintainsEqual-Weight
Jun 2019DowngradesNeutralSell

View More Analyst Ratings for FDS
View the Latest Analyst Ratings

Posted-In: Morgan Stanley Toni KaplanAnalyst Color Downgrades Price Target Analyst Ratings

 

Related Articles (FDS)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
XELMaintains60.0
SOMaintains54.0
SREMaintains141.0
EXCMaintains56.0
ESMaintains77.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Mid-Day Market Update: Blue Apron Jumps On Beyond Meat Partnership; Tonix Pharmaceuticals Shares Plummet

41 Stocks Moving In Tuesday's Mid-Day Session